Identification and Prioritization of PET Neuroimaging Targets for Microglial Phenotypes Associated with Microglial

Nicole D Bartolo1, Niall Mortimer2, Mariah A Manter1

  • 1Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Charlestown, Massachusetts 02129, United States.

ACS Chemical Neuroscience
|December 6, 2022
PubMed

Insights

Researchers identified 19 microglia-specific genes for molecular imaging in neurodegenerative diseases like Alzheimer's disease (AD). This discovery aids in understanding disease mechanisms and developing new therapeutic targets.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Microglial cell activation is a hallmark of neurodegenerative disorders, including Alzheimer's disease (AD).
  • Understanding microglia's role in pathogenesis is crucial for developing effective treatments.
  • Molecular imaging tools targeting microglia can illuminate their contribution to disease progression.

Purpose of the Study:

  • To identify and rank microglia-specific genes for potential use in molecular imaging.
  • To find novel targets for understanding neurodegenerative disease mechanisms.
  • To evaluate gene candidates based on AD association, expression changes, and druggability.

Main Methods:

  • Analysis of publicly available genetic, transcriptomic, and proteomic datasets.
  • Identification of genes exhibiting microglia-specific expression patterns.
  • Ranking of identified genes based on relevance to AD characteristics, expression variability, and therapeutic potential.

Main Results:

  • 19 genes with high microglia-specific expression were identified.
  • Genes were ranked according to their association with AD, expression changes, and druggability.
  • The study provides a ranked list of potential molecular imaging and therapeutic targets.

Conclusions:

  • The developed methodology for identifying and ranking microglia-specific genes is robust.
  • This approach can be applied to discover targets in other diseases and for various applications beyond imaging.
  • The identified genes represent promising candidates for advancing the study and treatment of neurodegenerative disorders.